Long-term Study in Chronic Kidney Disease (Extension From Study 14817)
Status:
Completed
Trial end date:
2013-04-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to investigate the safety and the effect on reduction of serum
phosphate of long-term administration of lanthanum carbonate (BAY77-1931) 750 to 2250 mg in
patients with hyperphosphatemia who completed the 8 week double-blind treatment period of
Study 14817 and are judged to be eligible for the long-term extension study.